Freenome, Inc. Common stock

FRNMNASDAQUSD
13.99 USD
0.21 (1.52%)AT CLOSE (11:59 AM EDT)
14.00
0.01 (0.08%)
POST MARKET (AS OF 07:32 PM EDT)
Post Market
AS OF 07:32 PM EDT
14.00
0.01 (0.08%)
🟢Market: OPEN

FRNM is currently priced at $14.00. The technical outlook is "Strong Buy" based on moving average alignment, RSI, and MACD signals. Key drivers include a bullish Golden Cross on the moving averages.

Technical & fundamental data as of Aug 25, 2026.

Open?$13.76
High?$14.18
Low?$13.69
Prev. Close?$13.78
Volume?476.0K
Avg. Volume?N/A
VWAP?$13.97
Bid / Ask
Bid?$11.93 × 100
Ask?$15.96 × 100
Spread?$4.03
Midpoint?$13.95
Valuation & Ratios
Market Cap?1.5B
Shares Out?N/A
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Freenome Inc is a development-stage, early cancer detection company developing blood-based screening tests leveraging a proprietary artificial intelligence/machine learning multiomics technology platform to transform multi-cancer and ultimately multi-disease detection. It is developing a range of blood-based cancer screening tests.
Employees
N/A
Market Cap
1.5B
Industry
SERVICES-MEDICAL LABORATORIES
Listed
2026-07-21
Address
51 ASTOR PLACE, 10TH FLOOR
NEW YORK, NY 10003
Phone: 212-284-2300
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+3/3)
Medium-Term (Wave)? Bullish(+3/3)
Short-Term (Ripple)? Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestLow
Short Interest?1.4M
Days to Cover?1.8
Avg Daily Volume808.7K
Settlement Date2026-08-14